A tracheal aspirate from which parainfluenza 2 (PI-2) virus but not chlamydia was isolated demonstrated positive immunofluorescence of elementary body-and reticulate body-like particles on direct examination with anti-chlamydia monoclonal antibodies (Syva Co.) To learn more about the nature and extent of this crossreactivity, we obtained 18 additional PI-2 isolates: 3 from Boston (Kenneth McIntosh), 12 from Houston (Paul Glezen), and 3 from our own laboratory. No clinical data were available regarding the patients from whom these isolates were obtained. These isolates were inoculated into RMK cell (University of Chicago) culture tubes, and the cells were harvested when they were strongly hemadsorption positive. Suspensions of infected cells were spotted onto 12-well (4-mm-diameter) slides, air dried, fixed in cold acetone for 10 min, and stored at -90°C before they were stained.
A tracheal aspirate specimen was simultaneously evaluated by both viral and chlamydial culture techniques and led us to examine the possibility that Chlamydia trachomatis and parainfluenza virus 2 12 from Houston (Paul Glezen), and 3 from our own laboratory. No clinical data were available regarding the patients from whom these isolates were obtained. These isolates were inoculated into RMK cell (University of Chicago) culture tubes, and the cells were harvested when they were strongly hemadsorption positive. Suspensions of infected cells were spotted onto 12-well (4-mm-diameter) slides, air dried, fixed in cold acetone for 10 min, and stored at -90°C before they were stained.
We then determined the reaction of each strain with the following: PI-2 polyclonal antiserum (National Institute of Allergy and Infectious Diseases) raised to the Greer strain of PI-2 by using a biotin-avidin rhodamine system, the OMP reagent, and the fluoresceinated monoclonal antibodies (Bartels Immunodiagnostics) directed to the chlamydial lipopolysaccharide reagent. Cells of strains that exhibited staining with the chlamydia monoclonal antibodies were stained simultaneously with the PI-2 antiserum by using a biotinavidin system of rhodamine as the chromagen and the fluoresceinated chlamydia monoclonal antibody to examine for concordance of the staining pattern. They were then examined by fluorescence microscopy, and suitable fields were successively photographed under illumination appropriate for fluorescein and rhodamine, thereby enabling each staining pattern to be examined independently.
All viral strains reacted with the PI-2 viral antiserum. In addition to the strain from our patient, 3 strains (1 from Boston and 2 from Houston) of the 18 additional viral isolates also stained with the OMP reagent. None of the 19 isolates demonstrated positive stainingWith the lipopolysaccharide reagent. In the double labeling experiment, the pattern of staining of the cells with the PI-2 antiserum and the OMP reagent was identical (Fig. 1) .
Antigenic cross-reactivity could because by a shared antigenic determinant or by a close resemblance between antigenic determinants. Many examples of antigenic mimicry exist. There are reports of chlamydial antigenic components cross-reacting with other species, i.e., Acinetobacter anitratus and Coxiella burnetii (1, 4, 10) . However, a crossreaction between chlamydia and a viral antigen has not been described previously.
PI-2, one of four serotypes of parainfluenza virus, is a common cause of respiratory infection in children. It is believed to have at least seven viral polypeptides, including the fusion (F) and hemagglutinin and neuraminidase (HN) glycoproteins (9) . These glycoproteins are common to all the parainfluenza viruses and correspond to the glycoproteins of the simian virus SV-5. Antigenic variation is frequent among human PI-3 viruses and has also been described among clinical strains of mumps virus, another member of the paramyxovirus group (7) . Van onstrated (3) . Furthermore, the cleavage products of the F protein may vary from strain to strain (6, 11) . This variability might account for the fact that positive immunofluorescence with the C. trachomatis monoclonal antibodies was observed in only 3 of 18 additional PI-2 isolates, suggesting that one of these proteins is involved in this cross-reaction. It is unclear which of the proteins of these isolates shares a common antigenic determinant with the chlamydial OMP. Nonetheless, a shared antigenic determinant may lead to an error in clinical diagnoses.
Direct staining of respiratory tract secretions with the OMP reagent may show positive fluorescence when the patient does not have chlamydial pneumonia, but rather PI-2 infection. This misdiagnosis may cause the initiation of unnecessary antimicrobial therapy; therefore, the OMP reagent should not be used for direct staining of respiratory specimens without the benefit of culture confirmation. In addition, one should be cautious to interpret all positive laboratory findings within the clinical context of the patient. However, in the appropriate clinical setting, rapid viral diagnosis with monoclonal antibodies can be a highly useful tool.
